Regeneron (REGN) Announces FDA Approval of Kevzara

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. VRTS
7. SPY
8. NTAP
9. NTSK
10. OLLI

Go back to Regeneron (REGN) Announces FDA Approval of Kevzara
Regeneron (NASDAQ: REGN) Delayed: 854.92 +2.89 (0.34%)
Previous Close $852.03    52 Week High $592.36 
Open $858.19    52 Week Low $325.35 
Day High $859.34    P/E 224.39 
Day Low $853.76    EPS $3.81 
Volume 19,850